Other

Debt issued (Note 13)

Thermo Fisher Scientific Debt issued (Note 13) increased by 84.4% to $5.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 84.4%, from $2.84B to $5.24B.

Analysis

StatementIncome Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026May 1, 2026

How to read this metric

High proceeds indicate active debt financing to support growth or liquidity, while low proceeds may suggest reliance on internal cash or limited market access.

Detailed definition

Cash inflows received from the issuance of long-term debt instruments, such as bonds or bank loans. This metric reflects...

Peer comparison

Standard financing activity metric across all capital-intensive industries.

Metric ID: other_proceeds_from_issuance_of_long_term_debt

Historical Data

9 periods
 Q2 '21Q3 '21Q1 '23Q2 '23Q1 '24Q2 '24Q3 '24Q1 '25Q1 '26
Value$0.00$3.12B$0.00$0.00$1.21B-$1.00M$0.00$2.84B$5.24B
QoQ Change-100.0%-100.1%+100.0%+84.4%
YoY Change+135.7%+84.4%
Range-$1.00M$5.24B
Avg YoY Growth+110.1%
Median YoY Growth+110.1%
Current Streak3 quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's debt issued (note 13)?
Thermo Fisher Scientific (TMO) reported debt issued (note 13) of $5.24B in Q1 2026.
How has Thermo Fisher Scientific's debt issued (note 13) changed year-over-year?
Thermo Fisher Scientific's debt issued (note 13) increased by 84.4% year-over-year, from $2.84B to $5.24B.
What does debt issued (note 13) mean?
Cash raised through the issuance of long-term debt.